{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:23:54Z","timestamp":1792121034495,"version":"4.4.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.eururo.2011.09.027","type":"journal-article","created":{"date-parts":[[2011,10,12]],"date-time":"2011-10-12T19:29:48Z","timestamp":1318447788000},"page":"112-127","source":"Crossref","is-referenced-by-count":248,"title":["Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the Literature"],"prefix":"10.1016","volume":"61","author":[{"given":"Lars","family":"Bud\u00e4us","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Cozzarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Widmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2011.09.027_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2007.09.002","article-title":"EAU guidelines on prostate cancer","volume":"53","author":"Heidenreich","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1200\/JCO.2009.26.0133","article-title":"Time trends and local variation in primary treatment of localized prostate cancer","volume":"28","author":"Cooperberg","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3816\/CGC.2005.n.007","article-title":"Patient preferences in prostate cancer: a clinician's guide to understanding health utilities","volume":"4","author":"Kramer","year":"2005","journal-title":"Clin Prostate Cancer"},{"key":"10.1016\/j.eururo.2011.09.027_bib0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/COC.0b013e3181a44ebe","article-title":"Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis","volume":"33","author":"Jani","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0025","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ijrobp.2004.12.052","article-title":"Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy","volume":"62","author":"Vargas","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijrobp.2007.12.045","article-title":"Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer","volume":"72","author":"Chan","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0360-3016(00)01414-0","article-title":"Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms","volume":"49","author":"Jackson","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0040","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.ijrobp.2005.10.002","article-title":"Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer","volume":"64","author":"Peeters","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-8140(02)00147-0","article-title":"Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions","volume":"64","author":"Fiorino","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0050","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.ijrobp.2007.07.2354","article-title":"Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study","volume":"70","author":"Fiorino","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2008.10.086","article-title":"Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer","volume":"75","author":"Fiorino","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2009.09.004","article-title":"Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study","volume":"93","author":"Fellin","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0065","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2008.10.021","article-title":"To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy","volume":"74","author":"Valdagni","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0070","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0360-3016(98)00091-1","article-title":"Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer","volume":"41","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0075","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0080","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2011.09.027_bib0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0090","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0360-3016(00)01428-0","article-title":"Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis","volume":"49","author":"Teh","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0095","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","article-title":"Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer","volume":"70","author":"Zelefsky","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2008.04.063","article-title":"Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer","volume":"73","author":"Al-Mamgani","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijrobp.2007.10.004","article-title":"Ultra-high dose (86.4Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes","volume":"71","author":"Cahlon","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2008.07.027","article-title":"Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy","volume":"89","author":"De Meerleer","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.06.011","article-title":"Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area","volume":"84","author":"Arcangeli","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0120","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.ejca.2009.07.009","article-title":"Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991","volume":"45","author":"Matzinger","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2011.09.027_bib0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2007.07.013","article-title":"Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer","volume":"84","author":"Cozzarini","year":"2007","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.eururo.2011.09.027_bib0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2008.03.021","article-title":"Hypofractionated adjuvant radiotherapy with helical tomotherapy after radical prostatectomy: planning data and toxicity results of a phase I-II study","volume":"88","author":"Cozzarini","year":"2008","journal-title":"Radiother Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.eururo.2011.09.027_bib0135","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation dose-volume effects in radiation-induced rectal injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0140","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.ijrobp.2004.04.014","article-title":"Fractionation and late rectal toxicity","volume":"60","author":"Brenner","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 3","key":"10.1016\/j.eururo.2011.09.027_bib0145","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ijrobp.2009.08.074","article-title":"The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome","volume":"76","author":"Jackson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0150","unstructured":"Oxford Centre for Evidence-based Medicine Levels of Evidence. website: http:\/\/www.cebmnet\/indexaspx?o=1025; accessed: July 13, 2011."},{"key":"10.1016\/j.eururo.2011.09.027_bib0155","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68Gy of radiotherapy with 78Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0160","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/cncr.24223","article-title":"Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management","volume":"115","author":"Phan","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2011.09.027_bib0165","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","article-title":"Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68Gy to 78Gy","volume":"61","author":"Peeters","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0170","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ijrobp.2004.07.695","article-title":"Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding","volume":"60","author":"Akimoto","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0360-3016(98)00460-X","article-title":"Diabetes mellitus: a predictor for late radiation morbidity","volume":"43","author":"Herold","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0360-3016(99)00560-X","article-title":"Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response","volume":"47","author":"Skwarchuk","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0185","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.ijrobp.2006.10.040","article-title":"Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study","volume":"67","author":"Vavassori","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0190","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.ijrobp.2003.09.015","article-title":"Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer","volume":"58","author":"Cheung","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0195","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0360-3016(02)03742-2","article-title":"Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer","volume":"54","author":"Huang","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0200","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0360-3016(02)04117-2","article-title":"Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2Gy)","volume":"55","author":"Cozzarini","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0205","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0360-3016(03)00665-5","article-title":"Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer","volume":"57","author":"Fiorino","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0167-8140(99)00027-4","article-title":"Is there more than one late radiation proctitis syndrome?","volume":"51","author":"Denham","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijrobp.2006.03.055","article-title":"Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage","volume":"66","author":"Heemsbergen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0220","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.juro.2006.06.002","article-title":"Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer","volume":"176","author":"Zelefsky","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0225","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70Gy at 2.5Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0230","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2007.01.043","article-title":"Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer","volume":"68","author":"Vora","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0235","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0360-3016(00)00550-2","article-title":"Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer","volume":"47","author":"Zelefsky","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0360-3016(00)00632-5","article-title":"Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer","volume":"48","author":"Gelblum","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0245","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0360-3016(01)01442-0","article-title":"Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis","volume":"50","author":"Snyder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0250","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2009.08.004","article-title":"Dose-volume effects for normal tissues in external radiotherapy: pelvis","volume":"93","author":"Fiorino","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0255","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.brachy.2007.08.008","article-title":"The impact of acute urinary morbidity on late urinary function after permanent prostate brachytherapy","volume":"6","author":"Bittner","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.eururo.2011.09.027_bib0260","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ijrobp.2006.10.042","article-title":"Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer","volume":"67","author":"Cheung","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0265","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ijrobp.2007.04.076","article-title":"Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study","volume":"69","author":"Harsolia","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0270","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00345-008-0305-9","article-title":"Does radical treatment have a role in the management of low-risk prostate cancer? The place for brachytherapy and external beam radiotherapy","volume":"26","author":"Williams","year":"2008","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0275","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2011.09.027_bib0280","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2004.07.026","article-title":"Factors predicting for urinary morbidity following 125iodine transperineal prostate brachytherapy","volume":"73","author":"Williams","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0285","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijrobp.2007.12.024","article-title":"Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer","volume":"72","author":"Ferrer","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0290","first-page":"975","article-title":"Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative. Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer","volume":"164","author":"Crook","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.eururo.2011.09.027_bib0295","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijrobp.2009.04.078","article-title":"A phase III randomized trial of the timing of meloxicam with iodine-125 prostate brachytherapy","volume":"77","author":"Crook","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0300","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0360-3016(01)02658-X","article-title":"Factors influencing risk of acute urinary retention after TRUS-guided permanent prostate seed implantation","volume":"52","author":"Crook","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0305","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2007.05.020","article-title":"A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer","volume":"84","author":"Ash","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0310","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0360-3016(02)04279-7","article-title":"Dysuria after permanent prostate brachytherapy","volume":"55","author":"Merrick","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0315","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1464-410X.2006.05887.x","article-title":"Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy","volume":"97","author":"Gutman","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2011.09.027_bib0320","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.radonc.2006.11.006","article-title":"Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds","volume":"82","author":"Bottomley","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0325","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1464-410X.2003.04658.x","article-title":"The benefits of radical prostatectomy beyond cancer control in symptomatic men with prostate cancer","volume":"93","author":"Kumar","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2011.09.027_bib0330","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(99)00176-5","article-title":"Urinary morbidity following ultrasound-guided transperineal prostate seed implantation","volume":"45","author":"Gelblum","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0335","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10147-006-0584-3","article-title":"Serial changes of international prostate symptom score following I-125 prostate brachytherapy","volume":"11","author":"Ohashi","year":"2006","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0340","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0022-5347(01)62542-4","article-title":"Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate","volume":"160","author":"Terk","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0345","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.ju.0000152698.20487.0e","article-title":"Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy","volume":"173","author":"Kollmeier","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0350","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.urology.2007.04.042","article-title":"Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy","volume":"70","author":"Mabjeesh","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2011.09.027_bib0355","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brachy.2005.12.002","article-title":"Relationship of the International Prostate Symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy","volume":"5","author":"Martens","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.eururo.2011.09.027_bib0360","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijrobp.2004.09.036","article-title":"Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study","volume":"62","author":"Elshaikh","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0365","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.urology.2006.10.001","article-title":"Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years","volume":"69","author":"Stone","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2011.09.027_bib0370","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11255-007-9247-1","article-title":"Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment","volume":"40","author":"Akbal","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0375","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.pcan.4500938","article-title":"An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma","volume":"10","author":"Brown","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2011.09.027_bib0380","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ijrobp.2007.05.023","article-title":"TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy","volume":"70","author":"Peters","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0385","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.eururo.2008.03.026","article-title":"Erectile dysfunction after external beam radiotherapy for prostate cancer","volume":"55","author":"Pinkawa","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0390","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jama.1984.03340310017012","article-title":"Radiation-associated impotence. A clinical study of its mechanism","volume":"251","author":"Goldstein","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2011.09.027_bib0395","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0360-3016(85)90059-8","article-title":"A study of penile circulation before and after radiation in patients with prostate cancer and its effect on impotence","volume":"11","author":"Mittal","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0400","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2009.04.004","article-title":"Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: a comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and helical tomotherapy","volume":"93","author":"Perna","year":"2009","journal-title":"Radiother Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.eururo.2011.09.027_bib0405","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.ijrobp.2009.04.094","article-title":"Radiation dose-volume effects and the penile bulb","volume":"76","author":"Roach","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0410","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2007.07.018","article-title":"Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review","volume":"84","author":"van der Wielen","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0415","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2006.12.015","article-title":"Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial","volume":"68","author":"van der Wielen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0420","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/COC.0b013e318173a563","article-title":"Erectile dysfunction after radiotherapy for prostate cancer","volume":"32","author":"Mendenhall","year":"2009","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0425","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijrobp.2006.01.037","article-title":"Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography","volume":"65","author":"Gillan","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0430","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijrobp.2004.04.070","article-title":"Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI","volume":"61","author":"McLaughlin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0435","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0360-3016(02)04164-0","article-title":"Role of IMRT in reducing penile doses in dose escalation for prostate cancer","volume":"55","author":"Sethi","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0440","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1259\/bjr\/37893924","article-title":"Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer","volume":"77","author":"Kao","year":"2004","journal-title":"Br J Radiol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0445","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0360-3016(03)01617-1","article-title":"Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment","volume":"58","author":"Buyyounouski","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0450","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0090-4295(99)00032-1","article-title":"Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation","volume":"54","author":"Turner","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2011.09.027_bib0455","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0022-5347(05)67900-1","article-title":"Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study","volume":"163","author":"Johannes","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0460","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1743-6109.2008.01089.x","article-title":"Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy","volume":"6","author":"Salomon","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2011.09.027_bib0465","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.brachy.2006.11.003","article-title":"Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS","volume":"6","author":"Zagar","year":"2007","journal-title":"Brachytherapy"},{"key":"10.1016\/j.eururo.2011.09.027_bib0470","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.juro.2007.03.140","article-title":"Erectile function outcome reporting after clinically localized prostate cancer treatment","volume":"178","author":"Burnett","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0475","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijrobp.2004.12.056","article-title":"Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?","volume":"63","author":"Macdonald","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0480","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.urolonc.2009.01.001","article-title":"Does one have a sexual life 15 years after external beam radiotherapy for prostate cancer? Prospective patient-reported outcome of sexual function comparison with age-matched controls","volume":"29","author":"Fransson","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0485","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1056\/NEJMoa0810095","article-title":"Duration of androgen suppression in the treatment of prostate cancer","volume":"360","author":"Bolla","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2011.09.027_bib0490","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(08)61815-2","article-title":"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7\/SFUO-3): an open randomised phase III trial","volume":"373","author":"Widmark","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2011.09.027_bib0495","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.critrevonc.2005.06.006","article-title":"Sexual function after external-beam radiotherapy for prostate cancer: what do we know?","volume":"57","author":"Incrocci","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0500","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0090-4295(03)00133-X","article-title":"Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer","volume":"62","author":"Incrocci","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2011.09.027_bib0505","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1464-410X.2006.06441.x","article-title":"Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function","volume":"98","author":"Schiff","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2011.09.027_bib0510","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.radonc.2006.07.037","article-title":"Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397)","volume":"80","author":"Mangar","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0515","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1464-410X.2006.06398.x","article-title":"Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation","volume":"98","author":"Lehrer","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2011.09.027_bib0520","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1464-410X.2007.07016.x","article-title":"Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up","volume":"100","author":"Cesaretti","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2011.09.027_bib0525","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.urology.2009.04.101","article-title":"Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged < or = 55 years with favorable prostate cancer","volume":"75","author":"Gomez-Iturriaga Pina","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2011.09.027_bib0530","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/sj.ijir.3901271","article-title":"Sexual function after permanent 125I-brachytherapy for prostate cancer","volume":"17","author":"Mabjeesh","year":"2005","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2011.09.027_bib0535","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1200\/JCO.2008.20.9460","article-title":"Is there a standard of care for pathologic stage T3 prostate cancer?","volume":"27","author":"Thompson","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0540","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(05)67101-2","article-title":"Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)","volume":"366","author":"Bolla","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2011.09.027_bib0545","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1200\/JCO.2006.10.4505","article-title":"Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy","volume":"26","author":"Moinpour","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0550","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":"Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95","volume":"27","author":"Wiegel","year":"2009","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.eururo.2011.09.027_bib0555","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0959-8049(09)70027-9","article-title":"Salvage radiotherapy in patients with persisting\/rising PSA after radical prostatectomy for prostate cancer","volume":"45","author":"Bottke","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2011.09.027_bib0560","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ijrobp.2008.06.1922","article-title":"Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome\u2014results of a retrospective study","volume":"73","author":"Wiegel","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0565","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"25","author":"Stephenson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0570","first-page":"324","article-title":"Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy","volume":"4","author":"Do","year":"1998","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.eururo.2011.09.027_bib0575","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1200\/JCO.2001.19.6.1619","article-title":"Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer","volume":"19","author":"Madalinska","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0580","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ijrobp.2009.03.036","article-title":"Daily isocenter correction with electromagnetic-based localization improves target coverage and rectal sparing during prostate radiotherapy","volume":"76","author":"Rajendran","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0585","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00066-010-2071-z","article-title":"Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO++","volume":"186","author":"Wolff","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0590","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijrobp.2009.05.033","article-title":"Electromagnetic tracking of intrafraction prostate displacement in patients externally immobilized in the prone position","volume":"77","author":"Bittner","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0595","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijrobp.2008.05.059","article-title":"Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial","volume":"73","author":"King","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0600","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.2010.287","article-title":"Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer","volume":"303","author":"Talcott","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2011.09.027_bib0605","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.radonc.2008.10.022","article-title":"Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review","volume":"90","author":"Matzinger","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0610","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eururo.2007.10.070","article-title":"High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer","volume":"54","author":"Jeldres","year":"2008","journal-title":"Eur Urol"},{"issue":"Suppl 3","key":"10.1016\/j.eururo.2011.09.027_bib0615","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2009.08.075","article-title":"Guest editor's introduction to QUANTEC: a users guide","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0620","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-148-6-200803180-00209","article-title":"Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer","volume":"148","author":"Wilt","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2011.09.027_bib0625","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.radonc.2007.02.014","article-title":"The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)","volume":"83","author":"Dearnaley","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0630","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ijrobp.2008.10.091","article-title":"Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials","volume":"74","author":"Viani","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0635","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1200\/JCO.2005.09.662","article-title":"Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study","volume":"23","author":"Zapatero","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2011.09.027_bib0640","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2008.11.006","volume":"75","author":"Ishiyama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0645","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/cncr.22560","article-title":"Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"issue":"Suppl 3","key":"10.1016\/j.eururo.2011.09.027_bib0650","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.ijir.3900557","article-title":"Erectile function and quality of life after interstitial radiation therapy for prostate cancer","volume":"12","author":"Sanchez-Ortiz","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.eururo.2011.09.027_bib0655","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0360-3016(01)02675-X","article-title":"Erectile function after permanent prostate brachytherapy","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2011.09.027_bib0660","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ijc.1028","article-title":"Short-term sexual function after prostate brachytherapy","volume":"96","author":"Merrick","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2011.09.027_bib0665","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijrobp.2008.11.058","article-title":"Erectile function durability following permanent prostate brachytherapy","volume":"75","author":"Taira","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811011006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283811011006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T11:57:01Z","timestamp":1639137421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283811011006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0302283811011006"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2011.09.027","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}